Yıl 2024,
Cilt: 3 Sayı: 7, 121 - 129, 31.12.2024
Serap Gökçe Eskin
,
Ayşegül Kahraman
Kaynakça
- World Health Organisation (WHO) 2021 https://www.who.int/news-room/fact-sheets/detail/cancer (Accessed 14.01.2023)
- Yates P. Symptom Management and Palliative Care for Patients with Cancer. Nurs Clin North Am. 2017;52(1):179-191. doi: 10.1016/j.cnur.2016.10.006.
- Galizia D, Milani A, Geuna E, Martinello R, Cagnazzo C, Foresto M, Longo V, Berchialla P, Solinas G, Calori A, Grasso B, Volpone C, Bertola G, Parola G, Tealdi G, Giuliano PL, Ballari AM, Aglietta M, Montemurro F. Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study. Cancer Med. 2018;7(9):4339-4344. doi: 10.1002/cam4.1687.
- Jedličková H, Vokurka S, Vojtíšek R, Malečková A. Alopecia and Hair Damage Induced by Oncological Therapy. Klin Onkol. 2019;32(5):353-359. English. doi: 10.14735/amko2019353.
- Freites-Martinez A, Chan D, Sibaud V, Shapiro J, Fabbrocini G, Tosti A, Cho J, Goldfarb S, Modi S, Gajria D, Norton L, Paus R, Cigler T, Lacouture ME. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia. JAMA Dermatol. 2019; 1;155(6):724-728. doi: 10.1001/jamadermatol.2018.5071
- Williams LA, Ginex PK, Ebanks GL Jr, Ganstwig K, Ciccolini K, Kwong BK, Robison J, Shelton G, Strelo J, Wiley K, Maloney C, Moriarty KA, Vrabel M, Morgan RL. ONS Guidelines™ for Cancer Treatment-Related Skin Toxicity. Oncol Nurs Forum. 2020;47(5):539-556. doi: 10.1188/20.ONF.539-556
- Quesada S, Guichard A, Fiteni F. Cancer-Related Alopecia: From Etiologies to Global Management. Cancers (Basel). 2021 Nov 5;13(21):5556. doi: 10.3390/cancers13215556
- Kang D, Kim IR, Choi EK, Im YH, Park YH, Ahn JS, Lee JE, Nam SJ, Lee HK, Park JH, Lee DY, Lacouture ME, Guallar E, Cho J. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study. Oncologist. 2019;24(3):414-420. doi: 10.1634/theoncologist.2018-0184.
- Ates S, Olgun N. Chemotherapy induced alopecia and quality of life. Journal of Hacettepe University Faculty of Nursing. 2014;14(1):67-80.
- van Alphen K, Versluis A, Dercksen W, de Haas H, Lugtenberg R, Tiemensma J, Kroep J, Broadbent E, Kaptein AA, van den Hurk C. Giving A Face to Chemotherapy-Induced Alopecia: A Feasibility Study on Drawings by Patients. Asia Pac J Oncol Nurs. 2020; 7(2):218-224. doi: 10.4103/apjon.apjon_8_20
- Jayasinghe, R., Fernando, A., Jayarajah, U., & Seneviratne, S. (2021). Post treatment quality of life among Sri Lankan women with breast cancer. BMC cancer, 21(1), 305. https://doi.org/10.1186/s12885-021-08055-5
- Can G. Evidence to Practice Consensus in Oncology Nursing.p.183-185. Nobel Medicine Bookstores Tic. Ltd. Sti. Istanbul, 2014
- Cho J, Choi EK, Kim IR, Im YH, Park YH, Lee S, Lee JE, Yang JH, Nam SJ. Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients. Ann Oncol. 2014;25(2):346-51. doi: 10.1093/annonc/mdt476.
- Izgu N. Turkish adaptation of chemotherapy induced alopecia distress scale: a validity and reliability study. Turkiye Klinikleri J Nurs Sci.2020;12(2):227-35 doi: 10.5336/nurses.2019-73001
- Can G, Aydiner A. Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey. Eur J Oncol Nurs. 2011;15(1):3-11. doi: 10.1016/j.ejon.2009.10.010.
- Paterson C, Kozlovskaia M, Turner M, Strickland K, Roberts C, Ogilvie R, Pranavan G, Craft P. Identifying the supportive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review. J Cancer Surviv. 2021 Feb;15(1):14-28. doi: 10.1007/s11764-020-00907-6.
- Boland V, Brady AM, Drury A. The physical, psychological and social experiences of alopecia among women receiving chemotherapy: An integrative literature review. Eur J Oncol Nurs. 2020 Dec;49:101840. doi: 10.1016/j.ejon.2020.101840.
- Rohde GE, Young T, Winstanley J, Arraras JI, Black K, Boyle F, Bredart A, Costantini A, Guo J, Irarrazaval ME, Kobayashi K, Kruizinga R, Navarro M, Omidvari S, Serpentini S, Spry N, van Laarhoven H, Yang G, Vivat B. Associations between sex, age and spiritual well-being scores on the EORTC QLQ-SWB32 for patients receiving palliative care for cancer: A further analysis of data from an international validation study. Eur J Cancer Care (Engl). 2019;28(6):e13145. doi: 10.1111/ecc.13145
- Orth U, Erol RY, Luciano EC. Development of self-esteem from age 4 to 94 years: A meta-analysis of longitudinal studies. Psychol Bull. 2018;144(10):1045-1080. doi: 10.1037/bul0000161.
- Erol O, Can G, Aydıner A. Effects of alopecia on body image and quality of life of Turkish cancer women with or without headscarf. Support Care Cancer. 2012 ;20(10):2349-2356. doi: 10.1007/s00520-011-1338-y.
- Villar RR, Fernández SP, Garea CC, Pillado MTS, Barreiro VB, Martín CG. Quality of life and anxiety in women with breast cancer before and after treatment. Rev Lat Am Enfermagem. 2017;21-25:e2958. doi: 10.1590/1518-8345.2258.2958.
Alopecia due to chemotherapy and its effect on the wellbeing cancer patients
Yıl 2024,
Cilt: 3 Sayı: 7, 121 - 129, 31.12.2024
Serap Gökçe Eskin
,
Ayşegül Kahraman
Öz
Purpose: The present research is aimed to determine the effect of cancer symptoms of the patients on their well-being and the level of emotional distress that they experience due to alopecia.
Material and Methods: The population of this research with an analytical sectional design was comprised of the patients that received treatment in An University Hospital outpatient chemotherapy unit between the 1st of March and 1st of June in 2021 and met the research criteria. The number of samples was determined as 164 with G-power. Patient information form, Chemotherapy-Induced Alopecia Distress Scale, and Nightingale Symptom Assessment Scale were among the tools for data collection. The data were analysed with the SPSS package program and a correlation analysis was conducted between descriptive statistics and average scale scores.
Results: According to the results of the research, the average age of the participants was determined to be 56.55 + 10.54. Participants’ both chemotherapy-induced alopecia distress scale and mean scores of sub-dimensions and Nightingale symptom assessment scale were found lower in the participants aged 61 and above.
Conclusion: It was found out that the alopecia-induced distress and symptom-related well-being of the participants were affected by their age, marital status, and non-chemotherapeutic treatment.
Etik Beyan
The study procedures were in accordance with and approved by the Institution Review Board of the Faculty of Health Science (date: 24.02.2021; number: 2021/009), Adnan Menderes University
Destekleyen Kurum
This research received no grant from any funding agency/sector.
Kaynakça
- World Health Organisation (WHO) 2021 https://www.who.int/news-room/fact-sheets/detail/cancer (Accessed 14.01.2023)
- Yates P. Symptom Management and Palliative Care for Patients with Cancer. Nurs Clin North Am. 2017;52(1):179-191. doi: 10.1016/j.cnur.2016.10.006.
- Galizia D, Milani A, Geuna E, Martinello R, Cagnazzo C, Foresto M, Longo V, Berchialla P, Solinas G, Calori A, Grasso B, Volpone C, Bertola G, Parola G, Tealdi G, Giuliano PL, Ballari AM, Aglietta M, Montemurro F. Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study. Cancer Med. 2018;7(9):4339-4344. doi: 10.1002/cam4.1687.
- Jedličková H, Vokurka S, Vojtíšek R, Malečková A. Alopecia and Hair Damage Induced by Oncological Therapy. Klin Onkol. 2019;32(5):353-359. English. doi: 10.14735/amko2019353.
- Freites-Martinez A, Chan D, Sibaud V, Shapiro J, Fabbrocini G, Tosti A, Cho J, Goldfarb S, Modi S, Gajria D, Norton L, Paus R, Cigler T, Lacouture ME. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia. JAMA Dermatol. 2019; 1;155(6):724-728. doi: 10.1001/jamadermatol.2018.5071
- Williams LA, Ginex PK, Ebanks GL Jr, Ganstwig K, Ciccolini K, Kwong BK, Robison J, Shelton G, Strelo J, Wiley K, Maloney C, Moriarty KA, Vrabel M, Morgan RL. ONS Guidelines™ for Cancer Treatment-Related Skin Toxicity. Oncol Nurs Forum. 2020;47(5):539-556. doi: 10.1188/20.ONF.539-556
- Quesada S, Guichard A, Fiteni F. Cancer-Related Alopecia: From Etiologies to Global Management. Cancers (Basel). 2021 Nov 5;13(21):5556. doi: 10.3390/cancers13215556
- Kang D, Kim IR, Choi EK, Im YH, Park YH, Ahn JS, Lee JE, Nam SJ, Lee HK, Park JH, Lee DY, Lacouture ME, Guallar E, Cho J. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study. Oncologist. 2019;24(3):414-420. doi: 10.1634/theoncologist.2018-0184.
- Ates S, Olgun N. Chemotherapy induced alopecia and quality of life. Journal of Hacettepe University Faculty of Nursing. 2014;14(1):67-80.
- van Alphen K, Versluis A, Dercksen W, de Haas H, Lugtenberg R, Tiemensma J, Kroep J, Broadbent E, Kaptein AA, van den Hurk C. Giving A Face to Chemotherapy-Induced Alopecia: A Feasibility Study on Drawings by Patients. Asia Pac J Oncol Nurs. 2020; 7(2):218-224. doi: 10.4103/apjon.apjon_8_20
- Jayasinghe, R., Fernando, A., Jayarajah, U., & Seneviratne, S. (2021). Post treatment quality of life among Sri Lankan women with breast cancer. BMC cancer, 21(1), 305. https://doi.org/10.1186/s12885-021-08055-5
- Can G. Evidence to Practice Consensus in Oncology Nursing.p.183-185. Nobel Medicine Bookstores Tic. Ltd. Sti. Istanbul, 2014
- Cho J, Choi EK, Kim IR, Im YH, Park YH, Lee S, Lee JE, Yang JH, Nam SJ. Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients. Ann Oncol. 2014;25(2):346-51. doi: 10.1093/annonc/mdt476.
- Izgu N. Turkish adaptation of chemotherapy induced alopecia distress scale: a validity and reliability study. Turkiye Klinikleri J Nurs Sci.2020;12(2):227-35 doi: 10.5336/nurses.2019-73001
- Can G, Aydiner A. Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey. Eur J Oncol Nurs. 2011;15(1):3-11. doi: 10.1016/j.ejon.2009.10.010.
- Paterson C, Kozlovskaia M, Turner M, Strickland K, Roberts C, Ogilvie R, Pranavan G, Craft P. Identifying the supportive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review. J Cancer Surviv. 2021 Feb;15(1):14-28. doi: 10.1007/s11764-020-00907-6.
- Boland V, Brady AM, Drury A. The physical, psychological and social experiences of alopecia among women receiving chemotherapy: An integrative literature review. Eur J Oncol Nurs. 2020 Dec;49:101840. doi: 10.1016/j.ejon.2020.101840.
- Rohde GE, Young T, Winstanley J, Arraras JI, Black K, Boyle F, Bredart A, Costantini A, Guo J, Irarrazaval ME, Kobayashi K, Kruizinga R, Navarro M, Omidvari S, Serpentini S, Spry N, van Laarhoven H, Yang G, Vivat B. Associations between sex, age and spiritual well-being scores on the EORTC QLQ-SWB32 for patients receiving palliative care for cancer: A further analysis of data from an international validation study. Eur J Cancer Care (Engl). 2019;28(6):e13145. doi: 10.1111/ecc.13145
- Orth U, Erol RY, Luciano EC. Development of self-esteem from age 4 to 94 years: A meta-analysis of longitudinal studies. Psychol Bull. 2018;144(10):1045-1080. doi: 10.1037/bul0000161.
- Erol O, Can G, Aydıner A. Effects of alopecia on body image and quality of life of Turkish cancer women with or without headscarf. Support Care Cancer. 2012 ;20(10):2349-2356. doi: 10.1007/s00520-011-1338-y.
- Villar RR, Fernández SP, Garea CC, Pillado MTS, Barreiro VB, Martín CG. Quality of life and anxiety in women with breast cancer before and after treatment. Rev Lat Am Enfermagem. 2017;21-25:e2958. doi: 10.1590/1518-8345.2258.2958.